Clinical Trials in Colorado

Showing 6721-6740 of 18,143 trials

Study Using Negative Pressure to Reduce Apnea

NCT04861038

The objective of this study is to determine the safety and effectiveness of the aerSleep® II device for treatment of moderate to severe Obstructive Sleep Apnea (OSA) over 24 weeks of home use in spontaneously breathing adult subjects who are intolerant of Continuous Positive Airway Pressure (CPAP) therapy.

Sleep Apnea, ObstructiveApnea, Sleep

Sommetrics, Inc.900 participantsStarted Nov 2021

Tucson, Arizona, United States • Little Rock, Arkansas, United States • Los Angeles, California, United States +12 more locations

No Longer Available50 miles

Expanded Access Program of Surufatinib

NCT04814732

This treatment protocol is intended to provide early access of surufatinib to patients with locally advanced or metastatic NETs for whom, in the opinion of their treating physician, other treatment options or surufatinib clinical trials in this indication are unsuitable. This EAP is currently available in the US only.

Neuroendocrine Tumors

Hutchmed

Denver, Colorado, United States • Baltimore, Maryland, United States • Detroit, Michigan, United States +8 more locations

Study Using Negative Pressure to Reduce Apnea

Expanded Access Program of Surufatinib

Find Trials by Condition in Colorado

Open-Label Extension Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome

The Safety and Efficacy Study of Ethylenediaminetetraacetic Acid (EDTA) Ophthalmic Solution in Patients With Loss of Contrast Sensitivity Due to Age-Related, Low-Grade Nuclear Cataract

A Maintenance Therapy Study of Odetiglucan With CDX-1140 in Patients With Metastatic Pancreatic Ductal Adenocarcinoma

Geriatric Assessment Intervention for Reducing Toxicity in Older Patients With Advanced Cancer

Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Lumbar Pain

Stories for Change: Early Detection Can Save Lives

Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BIIB107 in Healthy Adult Participants

Study to Evaluate the Safety and Pharmacokinetics of Efmarodocokin Alfa in Combination With Standard of Care in Participants Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Safety and Effectiveness Study of the Zenflow Spring System

DWI in Assessing Treatment Response in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy

Longitudinal Observation of Insulin Requirements and Sensor Use in Pregnancy

Study of PF-07263689 in Participants With Selected Advanced Solid Tumors

Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma

Safety, Tolerability, and Pharmacokinetics of UX053 in Patients With Glycogen Storage Disease Type III (GSD III)

Treatment of Peripheral Arterial Hemorrhage With Lava LES (The LAVA Study)

Financial Incentives, Randomization With Stepped Treatment Trial

Phase I/IIa Study of H002 in NSCLC With Active EGFR Mutation

Lyophilized Fecal Microbiome Transfer vs. Vancomycin Monotherapy for Primary Clostridioides Difficile Infection